<?xml version="1.0" encoding="UTF-8"?>
<p>In order to examine how inhibition of host gene expression affects the safety and immunogenicity of the MDV A/AA/6/60 LAIV, we built a plasmid-based reverse genetic system that we could manipulate to generate the recombinant viruses (
 <xref ref-type="fig" rid="pathogens-09-00086-f003">Figure 3</xref>). To this end we started with the plasmids encoding the six internal proteins from the MDV A/AA/6/60 LAIV, which contain the 5 mutations (PB2 N265S; PB1 K391E, E581G, A661T; and NP D34G) that confer the 
 <italic>ca</italic> and 
 <italic>ts</italic> phenotype to the MDV A/AA/6/60 LAIV (
 <xref ref-type="fig" rid="pathogens-09-00086-f003">Figure 3</xref>A) [
 <xref rid="B10-pathogens-09-00086" ref-type="bibr">10</xref>,
 <xref rid="B11-pathogens-09-00086" ref-type="bibr">11</xref>]. We then introduced synonymous mutations into the 
 <italic>PA</italic> gene at the frameshift (
 <xref ref-type="fig" rid="pathogens-09-00086-f003">Figure 3</xref>B), resulting in a PA expression plasmid that no longer generates PA-X (PA
 <sub>MT</sub>
 <sup>−</sup>) [
 <xref rid="B15-pathogens-09-00086" ref-type="bibr">15</xref>,
 <xref rid="B18-pathogens-09-00086" ref-type="bibr">18</xref>,
 <xref rid="B19-pathogens-09-00086" ref-type="bibr">19</xref>,
 <xref rid="B21-pathogens-09-00086" ref-type="bibr">21</xref>,
 <xref rid="B23-pathogens-09-00086" ref-type="bibr">23</xref>,
 <xref rid="B39-pathogens-09-00086" ref-type="bibr">39</xref>]. Last, we introduced two mutations into the 
 <italic>NS1</italic> gene (F103S and M106I) to change amino acids that have been shown in other IAV strains to be necessary to bind CPSF30 and carry out the host gene expression inhibitory function of NS1 (
 <xref ref-type="fig" rid="pathogens-09-00086-f003">Figure 3</xref>B) [
 <xref rid="B35-pathogens-09-00086" ref-type="bibr">35</xref>]. This set of plasmids allows us to look at the inhibitory effects of PA-X and NS1 separately and together during viral infection, allowing us to rescue the WT MDV A/AA/6/60 LAIV (PA
 <sub>WT</sub>
 <sup>+</sup>/NS1
 <sub>WT</sub>
 <sup>+</sup>), and three mutant MDV A/AA/6/60 LAIVs that have altered PA-X and/or NS1 functions (PA
 <sub>WT</sub>
 <sup>+</sup>/NS1
 <sub>MT</sub>
 <sup>−</sup>, PA
 <sub>MT</sub>
 <sup>−</sup>/NS1
 <sub>WT</sub>
 <sup>+</sup>, PA
 <sub>MT</sub>
 <sup>−</sup>/NS1
 <sub>MT</sub>
 <sup>−</sup>) (
 <xref ref-type="fig" rid="pathogens-09-00086-f003">Figure 3</xref>A).
</p>
